Concourse Financial Group Securities, Inc. Mersana Therapeutics, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$1.23 - $2.25 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$2.0 - $4.45 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$2.16 - $5.94 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$1.11 - $2.34 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$1.06 - $3.91 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$1.06 - $3.91 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$3.08 - $9.55 $0 - $0
Q1 2023 May 15, 2023	BUY	$4.0 - $7.02 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$5.65 - $7.86 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$4.63 - $8.0 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$2.84 - $5.0 $0 - $0
Q1 2022 May 09, 2022	BUY	$3.74 - $6.63 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$5.48 - $9.86 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$8.56 - $14.47 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$13.28 - $18.07 $0 - $0
Q1 2021 May 13, 2021	BUY	$15.31 - $26.52 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$16.84 - $27.59 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$16.2 - $25.7 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$5.24 - $23.4 $0 - $0
Q1 2020 May 13, 2020	BUY	$4.41 - $9.28 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$1.45 - $6.73 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$1.54 - $4.2 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$3.84 - $6.4 $0 - $0
Q1 2019 May 15, 2019	BUY	$3.51 - $7.3 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$3.45 - $9.72 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$10.0 - $19.02 $0 - $0

Others Institutions Holding MRSN

# of Institutions

125

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

Eco R1 Capital, LLC San Francisco, CA

19.4M
Shares

$10.5 Million
1.59% of portfolio
Nextech Invest Ag

12.1M
Shares

$6.52 Million
3.72% of portfolio
Vr Adviser, LLC New York, NY

11.3M
Shares

$6.12 Million
2.22% of portfolio
Bain Capital Life Sciences Investors, LLC Boston, MA

8.66M
Shares

$4.68 Million
2.94% of portfolio
Black Rock Inc. New York, NY

8.38M
Shares

$4.53 Million
0.0% of portfolio

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $52.5M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account